Table 3.
Demographic, clinical and laboratory data on all patients who died or were removed
| PSC | Non-PSC | P-Value | |
|---|---|---|---|
| Died/Removed, N (%)* | 432 (13.9) | 14,073 (20.9) | N/A |
| Wait time prior to removal, median (25th-75th percentile) |
451 (98-1154) | 320 (69-963) | N/A |
| Male gender, N(%) | 281 (65.1) | 8,627 (61.3) | N/A |
| Race/ethnicity | White-362 (83.8) | White: 10,019 | N/A |
| Black: 49 (11.3) | (71.2) | ||
| Hispanic: 16 (3.7) | Black: 1,022 | ||
| Asian: 5 (1.2) | (7.3) | ||
| Hispanic: 2,361 (16.8) |
|||
| Asian: 505 (3.6) | |||
| Variceal bleeding within 2 weeks of listing, N (%)† |
17 (4.4) | 810 (6.6) | 0.093 |
| History of ascites at listing, N(%)†‡ | 314 (78.5) | 11,376 (87.8) | <0.0001 |
| History of SBP at listing, N(%)† | 14 (3.5) | 864 (6.7) | 0.012 |
| History of hepatic encephalopathy at listing, N(%)†‡ |
172 (52.4) | 8,090 (71.5) | <0.0001 |
| Initial MELD | 17.8 ± 8.8 | 18.7 ± 9.5 | 0.2502 |
| Initial bilirubin, mg/dL | 8.6 + 10.0 | 5.8 ± 8.9 | <0.0001 |
| Initial INR | 1.4 ± 0.6 | 1.7 ± 1.1 | <0.0001 |
| Initial creatinine, mg/dL | 1.2 + 1.3 | 1.4 + 1.3 | <0.0001 |
| Final MELD | 24.6 ± 12.5 | 24.6 ± 12.6 | 0.97 |
| Final bilirubin, mg/dL | 14.0 ± 14.0 | 9.8 ± 12.4 | <0.0001 |
| Final INR | 2.2 ± 2.9 | 2.2 ± 2.2 | <0.0001 |
| Final creatinine, mg/dL | 1.6 ± 1.2 | 1.9 ± 1.5 | <0.0001 |
†
% is defined as percentage among those patients with available data
‡
Data available only on patients listed after February 26th, 2002. Presence of complication defined as dichotomous yes/no.